Bio-Rad Laboratories (BIO.B) Competitors $234.41 0.00 (0.00%) As of 05/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock BIO.B vs. KEYS, FTV, VLTO, TER, RVTY, AVTR, NVMI, VNT, MIR, and STShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Keysight Technologies (KEYS), Fortive (FTV), Veralto (VLTO), Teradyne (TER), Revvity (RVTY), Avantor (AVTR), Nova (NVMI), Vontier (VNT), Mirion Technologies (MIR), and Sensata Technologies (ST). These companies are all part of the "measuring and control equipment" industry. Bio-Rad Laboratories vs. Keysight Technologies Fortive Veralto Teradyne Revvity Avantor Nova Vontier Mirion Technologies Sensata Technologies Bio-Rad Laboratories (NYSE:BIO.B) and Keysight Technologies (NYSE:KEYS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership. Which has preferable earnings & valuation, BIO.B or KEYS? Keysight Technologies has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Keysight Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.57B2.56-$1.84B-$65.04-3.60Keysight Technologies$5.02B5.13$614M$3.4942.71 Which has more volatility & risk, BIO.B or KEYS? Bio-Rad Laboratories has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500. Comparatively, Keysight Technologies has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Do insiders & institutionals believe in BIO.B or KEYS? 0.0% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 84.6% of Keysight Technologies shares are owned by institutional investors. 28.4% of Bio-Rad Laboratories shares are owned by insiders. Comparatively, 0.6% of Keysight Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media refer more to BIO.B or KEYS? In the previous week, Keysight Technologies had 31 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 32 mentions for Keysight Technologies and 1 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.36 beat Keysight Technologies' score of 1.12 indicating that Bio-Rad Laboratories is being referred to more favorably in the media. Company Overall Sentiment Bio-Rad Laboratories Positive Keysight Technologies Positive Do analysts recommend BIO.B or KEYS? Keysight Technologies has a consensus price target of $181.33, suggesting a potential upside of 21.66%. Given Keysight Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Keysight Technologies is more favorable than Bio-Rad Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Keysight Technologies 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.78 Is BIO.B or KEYS more profitable? Keysight Technologies has a net margin of 12.32% compared to Bio-Rad Laboratories' net margin of -71.86%. Keysight Technologies' return on equity of 19.22% beat Bio-Rad Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories-71.86% 3.90% 2.76% Keysight Technologies 12.32%19.22%10.52% Does the MarketBeat Community prefer BIO.B or KEYS? Keysight Technologies received 357 more outperform votes than Bio-Rad Laboratories when rated by MarketBeat users. Likewise, 66.30% of users gave Keysight Technologies an outperform vote while only 57.60% of users gave Bio-Rad Laboratories an outperform vote. CompanyUnderperformOutperformBio-Rad LaboratoriesOutperform Votes12557.60% Underperform Votes9242.40% Keysight TechnologiesOutperform Votes48266.30% Underperform Votes24533.70% SummaryKeysight Technologies beats Bio-Rad Laboratories on 16 of the 18 factors compared between the two stocks. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO.B vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$6.57B$4.17B$5.54B$19.18BDividend YieldN/A0.57%5.09%4.00%P/E Ratio-3.6027.3222.7133.34Price / Sales2.564.31407.3529.24Price / Cash30.0336.1538.1817.52Price / Book1.001.656.804.54Net Income-$1.84B-$83.57M$3.22B$1.02B7 Day PerformanceN/A-1.53%2.16%1.85%1 Month Performance-3.13%-3.13%3.54%-2.36%1 Year Performance-16.26%-33.92%16.80%5.18% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIO.BBio-Rad LaboratoriesN/A$234.41flatN/A-16.3%$6.57B$2.57B-3.608,200Earnings ReportPositive NewsKEYSKeysight Technologies4.2964 of 5 stars$143.950.0%$181.33+26.0%+0.5%$24.88B$5.02B41.1315,000Short Interest ↑Positive NewsGap UpFTVFortive4.6199 of 5 stars$68.82-0.1%$81.92+19.0%-11.6%$23.39B$6.23B29.1618,000Earnings ReportNews CoveragePositive NewsVLTOVeralto2.9437 of 5 stars$92.05-0.3%$111.10+20.7%-0.3%$22.83B$5.19B27.5616,000Earnings ReportAnalyst ForecastInsider TradeShort Interest ↑Positive NewsTERTeradyne4.9523 of 5 stars$76.83-0.4%$118.94+54.8%-35.1%$12.36B$2.82B23.076,500Earnings ReportAnalyst ForecastBuyback AnnouncementOptions VolumeAnalyst RevisionGap UpRVTYRevvity3.7203 of 5 stars$95.00+0.8%$130.50+37.4%-9.4%$11.41B$2.76B42.9916,700Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading VolumeAVTRAvantor4.6562 of 5 stars$12.49-3.4%$19.32+54.7%-46.8%$8.51B$6.78B12.0114,500Earnings ReportAnalyst DowngradeHigh Trading VolumeNVMINova2.9942 of 5 stars$196.04-0.3%$264.60+35.0%+16.9%$5.74B$672.40M34.151,180Upcoming EarningsNews CoveragePositive NewsVNTVontier4.2682 of 5 stars$31.40+0.3%$43.17+37.5%-20.8%$4.66B$2.98B11.428,100Earnings ReportNews CoveragePositive NewsMIRMirion Technologies1.7193 of 5 stars$15.40+0.5%$18.75+21.8%+54.8%$3.58B$860.80M-81.052,870Earnings ReportNews CoveragePositive NewsSTSensata Technologies4.9077 of 5 stars$21.36+0.3%$33.33+56.1%-45.2%$3.19B$3.93B25.4320,800Upcoming EarningsPositive News Related Companies and Tools Related Companies KEYS Competitors FTV Competitors VLTO Competitors TER Competitors RVTY Competitors AVTR Competitors NVMI Competitors VNT Competitors MIR Competitors ST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO.B) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
